Abstract
One of the most clearly defined biochemical actions of the opiates is the receptor mediated inhibition of adenylate cyclase. Collier and Roy (1974) showed that cAMP accumulation in rat brain homogenates is inhibited by opiates, that the inhibition is blocked by the specific inhibitor, naloxone, and that the potencies of a series of opiate agonists as blockers of cAMP formation are similar to their potencies as analgesic agents. Soon thereafter, Sharma, et al, (1975a) found that the adenylate cyclase of neuroblastoma X glioma cell (NG108-15) membranes is in hibited by opiates in a similar, receptor mediated, fashion. The neuroblastoma X glioma hybrid cell NG108-15 homogenates provide an easily accessible source of opiate receptors (KLEE and NIRENBERG, 197 4) which remain coupled to adenylate cyclase more tenuously than those in brain homogenates seem to be. The NG108-15 system is therefore more easily reproducible (VAN INWAGEN, et al, 1975). In a parallel series of studies, Traber, et al, (1975a), using the same neuroblastoma X glioma hybrid cell line, have also shown that opiates decrease cellular cAMP levels.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
BRANDT, M., BUCHEN, C., and HAMPRECHT, B. (1977) Endorphins exert opiate-like action on neuroblastoma X glioma hybrid cells. FEBS Lett., 80, 251–254.
COLLIER, H. O. J., and ROY, A. C. (1974) Morphine-like drugs inhibit stimulation by E prostaglandins of cyclic AMP formation by rat brain homogenate. Nature , 248, 24–26.
COLLIER, H. 0. J. and FRANCIS, D. L. (1978) A Pharmacolo gical Analysis of Opiate Tolerance/Dependence in: The Bases of Addiction, edited by J. Fishman, Dahlem Konferenzen, Berlin. p. 281–298.
COLLIER, H. O. J., FRANCIS, D. L., MCDONALD-GIBSON, W. J., ROY, A. C., and SAEED, S. A. (197 5) Prostaglandins, cyclic AMP. and the mechanism of opiate dependence. Life Sci., 17, 86–90.
DOHAN, F. C. (1966) Cereals and schizophrenia: data and hypothesis. Acta Psychiat. Scand., 42, 125–152.
DOHAN, F. C., and GRASBERGER, J. C., 1973 Relapsed schizophrenics: earlier discharge from the hospital after cereal-free, milk-free diet. Amer. J. Psychiat., 130, 685–688.
GIAGNONI, G., SABOL, S. L., and NIRENBERG, M. (197 7) Synthesis of opiate peptides by a clonal pituitary tumor cell line. Proc. Natl. Acad. Sci. USA, 74, 2259-2263.
GOLDSTEIN, D. B., and GOLDSTEIN, A. (1961) Possible role of enzyme inhibition and repression in drug tolerance and addiction. Biochem. Pharmacol., 8, 48.
HIMMELSBACH, C. K. (1943) The morphine abstinence syndrome. Fed. Proc, 2 ,201–203.
IIJIMA, I., MINAMIKAWA, J., JACOBSON, A. E., BROSSI, A., RICE, K. C., and KLEE, W. A. (1978) Synthesis and biological properties of (+)-naloxone. J. Med. Chem., 21, 398–400.
KLEE, W. A., and NIRENBERG, M., (1974) A neuroblastoma X glioma hybrid cell with morphine receptors. Proc. Nat. Acad. Sci. USA, 71, 3474–3477.
KLEE, W. A., and NIRENBERG, M., (1976) Mode of action of endogenous opiate peptides. Nature, 263, 609–612.
KLEE, W. A., ZIOUDROU, C., and STREATY, R. A. (1978) Exorphins: peptides with opioid activity isolated from wheat gluten and their possible role in the etiology of schizophrenia. In: Endorphins in Mental Health Research, eds. E. Usdin, W. E. Bunney, and N. S. Kline, pp. 209–218. MacMillan, New York.
LAMPERT, A., NIRENBERG, M., and KLEE, W. A. (1976) Tolerance and dependence evoked by an endogenous opiate peptide. Proc. Natl. Acad. Sci. USA, 73, 3165–3167.
LORD, J. A. H., WATERFIELD, A. A., HUGHES, J., and KOSTERLITZ, H. W. (1976) Multiple opiate receptors. In: Opiates and Endogenous Opioid Peptides, edited by H. W. Kosterlitz, pp. 275–280. Elsevier, North Holland.
MATA, M. M., GAINER, H., and KLEE, W. A. (1977) Effect of dehydration on the endogenous opiate content of the rat neuro-intermediate lobe. Life Sci., 21, 1159–1162.
NATHANSON, N. M., KLEIN, W. L., and NIRENBERG, M. (1978) Regulation of adenylate cyclase activity mediated by muscarinic acetylcholine receptors. Proc. Natl. Acad. Sci. USA, 75, 1788–1792.
SABOL, S. L., and NIRENBERG, M. (1979) Regulation of adeny late cyclase of neuroblastoma X glioma hybrid cells by -adrenergic receptors. II. Long-lived increase of adenylate cyclase activity mediated by a-receptors. J. Biol. Chem., in-press.
SHARMA, S. K., NIRENBERG, M., and KLEE, W. A. (1975a) Morphine receptors as regulators of adenylate cyclase activity. Proc. Nat. Acad. Sci. USA, 72, 590–594.
SHARMA, S. K., KLEE, W. A., and NIRENBERG, M. (1975b) Dual regulation of adenylate cyclase account for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA, 72, 3092–3096.
SHARMA, S. K., KLEE, W. A., and NIRENBERG, M. (1977) Opiate-dependent modulation of adenylate cyclase. Proc. Natl. Acad. Sci., USA, 74, 3365–3369.
SHUSTER, L. (1961) Repression and de-repression of enzyme synthesis as a possible explanation of some aspects of drug action. Nature, 189, 314–315.
TRABER, J., FISCHER, K., LATZIN, S., and HAMPRECHT, B. (1975a) Morphine antagonizes action of prostaglandin in neuroblastoma and neuroblastoma X glioma hybrid cells. Nature, 253, 120–122.
TRABER, J., GULLIS, R., and HAMPRECHT, B. (1975b) Influence of opiates on the levels of adenosine 35 cyclic monophosphate in neuroblastoma X glioma hybrid cells. Life Sci., 16, 1863–1868.
VAN IUWEGEN, R. G., STRADA, S. J. and ROBISON, G. A. (1975) Effects of Prostaglandins and Morphine on Brain Adenylate Cyclase. Life Sci. 16, 1875–1876.
WAHLSTROM, A., BRANDT, M., MORODER, L., WUNSCH, E., LINDEBERG, G., RAGUARSSON, U., TERENIUS, L., and HAMPRECHT, B. (1977) Peptides related to 3-lipotropin with opioid activity. FEBS Lett., 77, 28–32.
ZIOUDROU, C., STREATY, R. A., and KLEE, W. A. (1979) Opioid peptides derived from food proteins: the exorphins. J. Biol. Chem., in press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Plenum Press, New York
About this chapter
Cite this chapter
Klee, W.A. (1979). Opioid Peptides as Modulators of Cyclic AMP Levels. In: Ehrlich, Y.H., Volavka, J., Davis, L.G., Brunngraber, E.G. (eds) Modulators, Mediators, and Specifiers in Brain Function. Advances in Experimental Medicine and Biology, vol 116. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3503-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3503-0_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3505-4
Online ISBN: 978-1-4684-3503-0
eBook Packages: Springer Book Archive